Literature DB >> 25446184

α-Enolase plays a catalytically independent role in doxorubicin-induced cardiomyocyte apoptosis and mitochondrial dysfunction.

Si Gao1, Hong Li2, Xiao-jun Feng2, Min Li2, Zhi-ping Liu2, Yi Cai3, Jing Lu2, Xiao-yang Huang2, Jiao-jiao Wang2, Qin Li2, Shao-rui Chen2, Jian-tao Ye4, Pei-qing Liu5.   

Abstract

BACKGROUND: α-Enolase is a glycolytic enzyme with "second jobs" beyond its catalytic activity. However, its possible contribution to cardiac dysfunction remains to be determined. The present study aimed to investigate the role of α-enolase in doxorubicin (Dox)-induced cardiomyopathy as well as the underlying mechanisms. EXPERIMENTAL APPROACHES: The expression of α-enolase was detected in rat hearts and primary cultured rat cardiomyocytes with or without Dox administration. An adenovirus carrying short-hairpin interfering RNA targeting α-enolase was constructed and transduced specifically into the heart by intramyocardial injection. Heart function, cell apoptosis and mitochondrial function were measured following Dox administration. In addition, by using gain- and loss-of-function approaches to regulate α-enolase expression in primary cultured rat cardiomyocytes, we investigated the role of endogenous, wide type and catalytically inactive mutant α-enolase in cardiomyocyte apoptosis and ATP generation. Furthermore, the involvement of α-enolase in AMPK phosphorylation was also studied. KEY
RESULTS: The mRNA and protein expression of cardiac α-enolase was significantly upregulated by Dox. Genetic silencing of α-enolase in rat hearts and cultured cardiomyocytes attenuated Dox-induced apoptosis and mitochondrial dysfunction. In contrast, overexpression of wide-type or catalytically inactive α-enolase in cardiomyocytes mimicked the detrimental role of Dox in inducing apoptosis and ATP reduction. AMPK dephosphorylation was further demonstrated to be involved in the proapoptotic and ATP-depriving effects of α-enolase.
CONCLUSION: Our findings provided the evidence that α-enolase has a catalytically independent role in inducing cardiomyocyte apoptosis and mitochondrial dysfunction, which could be at least partially contributed to the inhibition of AMPK phosphorylation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPK; Apoptosis; Cardiomyocyte; Doxorubicin; Mitochondria; α-Enolase

Mesh:

Substances:

Year:  2014        PMID: 25446184     DOI: 10.1016/j.yjmcc.2014.11.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials.

Authors:  Chen Yingzhong; Cai Lin; Wang Chunbin
Journal:  Springerplus       Date:  2016-07-19

2.  Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation.

Authors:  Srinivas Ayyadevara; Meenakshisundaram Balasubramaniam; Samuel Kakraba; Ramani Alla; Jawahar L Mehta; Robert J Shmookler Reis
Journal:  Antioxid Redox Signal       Date:  2017-06-28       Impact factor: 8.401

Review 3.  Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay.

Authors:  Leonardo Schirone; Luca D'Ambrosio; Maurizio Forte; Riccardo Genovese; Sonia Schiavon; Giulia Spinosa; Giuliano Iacovone; Valentina Valenti; Giacomo Frati; Sebastiano Sciarretta
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

4.  Adriamycin inhibits glycolysis through downregulation of key enzymes in Saccharomyces cerevisiae.

Authors:  Uma Priya Mohan; Selvaraj Kunjiappan; P B Tirupathi Pichiah; Sankarganesh Arunachalam
Journal:  3 Biotech       Date:  2021-01-02       Impact factor: 2.406

5.  Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Kangxing Song; Shuxia Wang; Dake Qi
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

6.  Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats.

Authors:  Menglin Liu; Menglong Wang; Jianfang Liu; Zhen Luo; Lei Shi; Ying Feng; Li Li; Lin Xu; Jun Wan
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

Review 7.  Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.

Authors:  Navid Koleini; Elissavet Kardami
Journal:  Oncotarget       Date:  2017-07-11

8.  Glibenclamide exacerbates adriamycin-induced cardiotoxicity by activating oxidative stress-induced endoplasmic reticulum stress in rats.

Authors:  Meng-Lin Liu; Meng-Long Wang; Jing-Jun Lv; Jie Wei; Jun Wan
Journal:  Exp Ther Med       Date:  2018-02-13       Impact factor: 2.447

Review 9.  Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.

Authors:  Nichanan Osataphan; Arintaya Phrommintikul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Cell Mol Med       Date:  2020-04-26       Impact factor: 5.310

10.  Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.

Authors:  Xiaotao Su; Shaohua Chen; Hongyu Lu; Haoyu Li; Chao Qin
Journal:  Drug Des Devel Ther       Date:  2021-06-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.